Table.
Summary of (1) primary end point (proportion of patients with IRRs after the first randomized dose) and severity, (2) IRRs at the first randomized dose leading to intervention in OCR infusion, (3) symptoms and management of IRRs, and (4) AEs
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.